← Leaderboards
Anthony E Pegg
Pennsylvania State Univ Hershey Med Ctr
$10,482,714
Attributed
$10,482,714
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–09$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$11,220,332 · 9
By mechanism
R01$7,630,931 · 4
R37$2,655,533 · 2
U19$933,868 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alkyltransferase”
- Stanton L Gerson · Case Western Reserve University$8,072,527
- F Peter Guengerich · Vanderbilt University$5,830,084
- Alan Clayton Sartorelli · Yale University$5,801,192
- Henry S. Friedman · Duke University$4,525,323
- John A Tainer · Scripps Research Institute$4,372,892
- Margaret R Spitz · University Of Texas Md Anderson Can Ctr$3,163,422
Research focus
AlkyltransferaseTissue /Cell CultureEnzyme ActivityPolyaminesSpermineEnzyme InhibitorsMutantEnzyme StructureAlkylating AgentsCarmustineSpermidineEnzyme Induction /RepressionEnzyme SubstrateOrnithine DecarboxylaseOligonucleotidesLaboratory MouseResearch StudyCarcinogenesisGenetically Modified AnimalsInhibitor/AntagonistAbbreviationsProtein Structure FunctionDna RepairActive Sites
Grant awards (40)
Persistence of Alkylated DNA Carcinogenesis$323,847
R37 · FY2009 · CA · contact PI
Investigations of Mammalian Aminopropyltransferases$77,288
R01 · FY2009 · GM · contact PI
Persistence of Alkylated DNA Carcinogenesis$323,847
R37 · FY2008 · CA · contact PI
Mammalian Polyamine Metabolism$313,665
R01 · FY2008 · CA · contact PI
Investigations of Mammalian Aminopropyltransferases$276,923
R01 · FY2008 · GM · contact PI
Alkyltransferase Inhibitors for Cancer Chemotherapy$250,931
R01 · FY2008 · CA · contact PI
Persistence of Alkylated DNA Carcinogenesis$323,847
R37 · FY2007 · CA · contact PI
Mammalian Polyamine Metabolism$313,665
R01 · FY2007 · CA · contact PI
Investigations of Mammalian Aminopropyltransferases$276,948
R01 · FY2007 · GM · contact PI
Alkyltransferase Inhibitors for Cancer Chemotherapy$250,931
R01 · FY2007 · CA · contact PI
Persistence of Alkylated DNA Carcinogenesis$332,567
R01 · FY2006 · CA · contact PI
Mammalian Polyamine Metabolism$323,033
R01 · FY2006 · CA · contact PI
Investigations of Mammalian Aminopropyltransferases$285,246
R01 · FY2006 · GM · contact PI
Alkyltransferase Inhibitors for Cancer Chemotherapy$258,426
R01 · FY2006 · CA · contact PI
Persistence of Alkylated DNA Carcinogenesis$340,625
R01 · FY2005 · CA
Investigations of Mammalian Aminopropyltransferases$292,137
R01 · FY2005 · GM
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY$274,022
R01 · FY2005 · CA
MAMMALIAN POLYAMINE METABOLISM$346,275
R37 · FY2004 · CA
Persistence of Alkylated DNA Carcinogenesis$340,677
R01 · FY2004 · CA
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY$274,109
R01 · FY2004 · CA
Investigations of Mammalian Aminopropyltransferases$274,050
R01 · FY2004 · GM
MAMMALIAN POLYAMINE METABOLISM$346,275
R37 · FY2003 · CA
Persistence of Alkylated DNA Carcinogenesis$306,485
R01 · FY2003 · CA
Investigations of Mammalian Aminopropyltransferases$274,050
R01 · FY2003 · GM
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY$239,567
R01 · FY2003 · CA
MAMMALIAN POLYAMINE METABOLISM$346,275
R37 · FY2002 · CA
Persistence of Alkylated DNA Carcinogenesis$306,534
R01 · FY2002 · CA
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY$239,649
R01 · FY2002 · CA
Investigations of Mammalian Aminopropyltransferases$234,900
R01 · FY2002 · GM
MAMMALIAN POLYAMINE METABOLISM$346,275
R37 · FY2001 · CA
PERSISTENCE OF ALKYLATED DNA IN CARCINOGENESIS$265,305
R01 · FY2001 · CA
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY$239,729
R01 · FY2001 · CA
Investigations of Mammalian Aminopropyltransferases$234,900
R01 · FY2001 · GM
INHIBITION OF DNA REPAIR TO ENHANCE CHEMOTHERAPY$737,618
U19 · FY2000 · CA
MAMMALIAN POLYAMINE METABOLISM$298,892
R37 · FY2000 · CA
PERSISTENCE OF ALKYLATED DNA IN CARCINOGENESIS$258,788
R01 · FY2000 · CA
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY$202,458
R01 · FY2000 · CA
INTERACTION OF BG AND RELATED COMPOUNDS WITH AGT$98,125
U19 · FY2000 · CA
CORE--IN VITRO TESTING OF AGT INHIBTORS$98,125
U19 · FY2000 · CA
MAMMALIAN AMINOPROPYLTRANSFERASES$73,323
R01 · FY2000 · GM